Eastman Chemical Company (EMN) has had a turbulent time according to various reports. Financial analysts' sentiment have shifted, with
RBC and
Wells Fargo downgrading the company due to weak demand and earnings.
Citi also adjusted their rating, though they have maintained a price target of $75. There's also a consensus among brokerages for a 'Moderate Buy' rating given to EMN. However, Q3 results were disappointing with both earnings and sales missing expectations, which led to an earnings and revenue miss in Q2. Despite the declining stock price, Eastman has sustained its dividends for 16 consecutive years due to strong cash generation and some investment firms, like Meritage Portfolio Management, have increased their stake in EMN. The company has also announced new leadership and is actively taking part in sustainability initiatives.
China also figures in their strategy, with plans to establish a cellulose acetate yarn manufacturing facility with Huafon Chemical. Despite these efforts, Eastman's outlook has been cut to negative by S&P, amid tariff impact and has been dropped from the
S&P 500 Value.
Eastman Chemical Company EMN News Analytics from Sat, 31 May 2025 07:00:00 GMT to Sat, 17 Jan 2026 17:09:12 GMT -
Rating -4
- Innovation 3
- Information 8
- Rumor -6
